Research Areas
DNA Structures for Cancer Therapy
Our research team creates structures from DNA and RNA as targeted medicines for the treatment of cancer. To do this, we study and control the fundamental self-assembly properties of DNA, polymers and supramolecular materials.
DNA Supramolecular Chemistry
Using only a minimal set of DNA strands, we build unique 3D structures for applications such as drug delivery and the organization of other materials. This strategy allows us to make complex constructs that will be useful for translation to clinical applications.
Expanding the DNA Toolbox
In the Sleiman lab, we work towards combining DNA with many other materials, including organic molecules, polymers, metal ions, and inorganic nanomaterials, to explore how DNA can be used to modify and organize these moieties. We make sequence-defined polymers with DNA, and study their ability to act as cancer therapies.
News
Hanadi Sleiman awarded 2024 E. W. R. Steacie Award
McGill University Newsroom
10 January 2024
McGill's Hanadi Sleiman wins 2021 Polanyi Award
McGill University Newsroom
17 November 2021
Two McGill Researchers receive $3.3M from NSERC CREATE program funding
McGill University Newsroom
11 July 2019
A cautionary tale for researchers working on selective drug delivery
McGill University Newsroom
10 May 2019
Hanadi Sleiman, C.J. Li awarded Killam Research Fellowships
McGill University Newsroom
8 May 2018
Using DNA as a printing press to create nanostructures
Chemical Institute of Canada News
May 2016
Building tailor-made DNA nanotubes step by step
McGill University Newsroom
23 February 2015
Complex functionality from DNA boxes and polymer snakes
JACS Article Spotlight
11 November 2014
